Moreover, reduced TMEFF2 mRNA levels were observed in the androgen-independent prostate cancer xenograft models (LAPC9-AI, LAPC3-AI and LAPC4-AI) when compared to their androgen-dependent counterparts. This evidence concerns the gene TMEFF2 and prostate cancer.